Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) EBT Margin (2016 - 2025)

Historic EBT Margin for CorMedix (CRMD) over the last 14 years, with Q3 2025 value amounting to 50.42%.

  • CorMedix's EBT Margin rose 746600.0% to 50.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 49.94%, marking a year-over-year increase of 3974600.0%. This contributed to the annual value of 44.45% for FY2024, which is 1351600000.0% down from last year.
  • According to the latest figures from Q3 2025, CorMedix's EBT Margin is 50.42%, which was up 746600.0% from 51.21% recorded in Q2 2025.
  • CorMedix's EBT Margin's 5-year high stood at 192678.48% during Q2 2023, with a 5-year trough of 100538.67% in Q3 2022.
  • Its 5-year average for EBT Margin is 9559.95%, with a median of 889.87% in 2024.
  • Its EBT Margin has fluctuated over the past 5 years, first soared by 2000000000bps in 2023, then crashed by -1944339900bps in 2024.
  • Quarter analysis of 5 years shows CorMedix's EBT Margin stood at 13814.54% in 2021, then tumbled by -100bps to 27637.7% in 2022, then skyrocketed by 369bps to 74310.64% in 2023, then crashed by -100bps to 43.14% in 2024, then increased by 17bps to 50.42% in 2025.
  • Its last three reported values are 50.42% in Q3 2025, 51.21% for Q2 2025, and 52.82% during Q1 2025.